Idebenone
Useful mainly for people with Leber's hereditary optic neuropathy (under specialist care).
Quick decision guide
May help most
people with Leber's hereditary optic neuropathy (under specialist care)
Common dosing range
900 mg/day in three divided doses for LHON; lower doses studied for general use
When to expect effects
Months for visual outcomes
Watch out for
Disease-specific drug use should be specialist-supervised; supplement-dose evidence is weak
What is it
Idebenone is a synthetic analog of coenzyme Q10 (ubiquinone) with a shorter side chain that improves water solubility and bioavailability. It is approved as a drug for Leber's hereditary optic neuropathy (LHON) in some countries and marketed as a supplement for mitochondrial support.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
leber's hereditary optic neuropathy (lhon) Good Evidence | Can stabilize or modestly improve visual function | people with genetically confirmed LHON, especially earlier in the disease | Months |
friedreich's ataxia Mixed Evidence | Inconsistent; no clear clinical benefit on neurological progression | studied in Friedreich's ataxia under specialist care | Months |
cognitive support Mixed Evidence | Unclear; not established | not established | Unknown |
leber's hereditary optic neuropathy (lhon)
- Effect
- Can stabilize or modestly improve visual function
- Best fit
- people with genetically confirmed LHON, especially earlier in the disease
- Time
- Months
friedreich's ataxia
- Effect
- Inconsistent; no clear clinical benefit on neurological progression
- Best fit
- studied in Friedreich's ataxia under specialist care
- Time
- Months
cognitive support
- Effect
- Unclear; not established
- Best fit
- not established
- Time
- Unknown
Evidence for 3 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
leber's hereditary optic neuropathy (lhon)
Disease adjunctIdebenone is approved in the EU and Canada (Raxone/Catena) for Leber's hereditary optic neuropathy, where controlled and observational data show it can stabilize or modestly improve visual function in some patients. Response is variable and the drug is used under specialist supervision. It acts as a mitochondrial electron carrier that may bypass complex I dysfunction.
Bottom line: An approved, specialist-directed therapy for LHON with modest, variable visual benefit.
friedreich's ataxia
Disease adjunctIdebenone has been studied in Friedreich's ataxia for cardiac and neurological endpoints, with some early signals on cardiac measures but no consistent benefit on neurological progression in larger trials. Overall results are mixed and it is not an established treatment. Use should be specialist-directed.
Bottom line: Evidence in Friedreich's ataxia is mixed and does not establish clear clinical benefit.
Evidence is mixed
Trials in Friedreich's ataxia are inconsistent, with no reliable effect on neurological progression despite some early cardiac signals.
cognitive support
Supplement benefitOlder studies explored idebenone for Alzheimer's disease and cognitive decline with inconsistent results, and it is not an established cognitive therapy. Marketing for general 'brain' or anti-aging benefit outpaces the evidence. Any cognitive effect remains unproven.
Bottom line: Not supported as a cognitive enhancer or dementia treatment.
Evidence is mixed
Cognition trials, mostly older and in Alzheimer's disease, are inconsistent and unconvincing.
How it works
How to take it
What to track
3 commercial forms
Compare the main delivery options and what they’re best suited for.
Idebenone (pharmaceutical)
Approved prescription product for LHON.
150 mg tablets (Raxone)
Idebenone supplement
Lower doses, less regulatory oversight.
Variable quality
Topical idebenone
Not systemic delivery.
Used in cosmetic antioxidant formulations
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Transient liver enzyme elevations
Who should avoid it
- Pregnant or breastfeeding women (insufficient data)
- Children except under specialist supervision
Pregnancy & breastfeeding
Insufficient safety data in pregnancy and lactation; avoid unless a specialist advises otherwise.
Interactions
Theoretical interaction
May enhance or interfere with their effects
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is idebenone the same as CoQ10?⌄
They are related but distinct. Idebenone has a shorter, more soluble side chain that improves cellular penetration. CoQ10 is the natural endogenous form.
Is idebenone a drug or a supplement?⌄
Both, depending on jurisdiction and use. It is an approved drug for LHON in some countries and is sold as a supplement in others.
References by claim
leber's hereditary optic neuropathy (lhon)
friedreich's ataxia
Track Idebenone with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.